Regarding CNS, animal models and patient samples have revealed that ENT1 and adenosine constitute biomarkers of the initial stages of neurodegeneration in Huntington disease with ENT1 transcript being significantly upregulated in those patients (Guitart et al., 2016). Here, SLC29A1 is linked to juvenile Huntington disease.